The most documented extrahepatic manifestation of hepatitis C virus (HCV) i
nfection is mixed cryoglobulinemia (MC). MC is characterised by the presenc
e of temperature-sensitive protein complexes: in type II MC, cryoglobulins
are composed of a monoclonal rheumatoid factor (usually, IgM kappa) against
polyclonal IgG. In type III MC, all components are polyclonal. The presenc
e of microheterogeneity and other new types of cryoglobulins is a novel and
recent observation. The production of different autoantibodies and circula
ting immune complexes, including the cryoglobulins, are responsible for sys
temic vasculitis and various organ damage. In a limited number of MC patien
ts, a malignancy, that is B-cell non-Hodgkin's lymphoma or hepatocellular c
arcinoma, may also develop. Finally, results of interferon and/or ribavirin
treatments in MC patients represent an indirect proof for the pathogenetic
link between MC and HVC infection. The discovery of the relation between H
CV infection and MC shows the striking association between a viral infectio
n and an autoimmune disease and, thus, a potential link between the systemi
c autoimmune and lymphoproliferative disorders.